Drugs interfering with mitochondrial disorders

References

• Ahn, M. S., Sims, K. B., Frazier, J. A. (2005). Risperidone-induced psychosis and depression in a child with a mitochondrial disorder. J Child Adolesc Psychopharmacol 15:520–525.
   PubMed Web of Science ®Google Scholar
• Aldakkak, M., Stowe, D. F., Chen, Q., Lesnefsky, E. J., Camara, A. K. (2008). Inhibited mitochondrial respiration by amobarbital during cardiac ischaemia improves redox state and reduces matrix Ca2+ overload and ROS release. Cardiovasc Res 77:406–415.
   PubMed Web of Science ®Google Scholar
• Aleisa, A. M., Al-Majed, A. A., Al-Yahya, A. A., Al-Rejaie, S. S., Bakheet, S. A., Al-Shabanah, O. A., et al. (2007). Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues. Clin Exp Pharmacol Physiol 34:1252–1259.
   PubMed Web of Science ®Google Scholar
• Allen, R. J., DiMauro, S., Coulter, D. L., Papadimitriou, A., Rothenberg, S. P. (1983). Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate. Ann Neurol 13:679–682.
   PubMed Web of Science ®Google Scholar
• Almawi, W. Y., Melemedjian, O. K., Jaoude, M. M. (2004). On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis. J Leukoc Biol 76:7–14.
   PubMed Web of Science ®Google Scholar
• Anderson, C. M., Norquist, B. A., Vesce, S., Nicholls, D. G., Soine, W. H., Duan, S., et al. (2002). Barbiturates induce mitochondrial depolarization and potentiate excitotoxic neuronal death. J Neurosci 22:9203–9209.
   PubMed Web of Science ®Google Scholar
• Angelini, C., Federico, A., Reichmann, H., Lombes, A., Chinnery, P., Turnbull, D. (2006). Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders. Eur J Neurol 13:923–929.
   PubMed Web of Science ®Google Scholar
• Aouad, M. T., Gerges, F. J., Baraka, A. S. (2005). Resistance to cis-atracurium in a patient with MELAS syndrome. Paediatr Anaesth 15:1124–1127.
   PubMed Web of Science ®Google Scholar
• Arenas, J, Fernández-Moreno, MA, Molina, JA, Fernández, V, del Hoyo, P, Campos, Y, et al. (2003). Myoglobinuria and COX deficiency in a patient taking cerivastatin and gemfibrozil. Neurology 60:124–126.
   PubMed Web of Science ®Google Scholar
• Artuch, R., Aracil, A., Mas, A., et al. (2002). Friedreich’s ataxia: idebenone treatment in early stage patients. Neuropediatrics 33:190–193.
   PubMed Web of Science ®Google Scholar
• Aure, K., Benoist, J. F., Ogier de Baulny, H., Romero, N. B., Rigal, O., Lombes, A. (2004). Progression despite replacement of a myopathic form of coenzyme Q10 defect. Neurology 63:727–729.
   PubMed Web of Science ®Google Scholar
• Balijepalli, S., Kenchappa, R. S., Boyd, M. R., Ravindranath, V. (2001). Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics. Neurochem Int 38:425–435.
   PubMed Web of Science ®Google Scholar
• Barisic, N., Bernert, G., Ipsiroglu, O., et al. (2002). Effects of oral creatine supplementation in a patient with MELAS phenotype and associated nephropathy. Neuropediatrics 33:157–161.
   PubMed Web of Science ®Google Scholar
• Bastin, J., Aubey, F., Rötig, A., Munnich, A., Djouadi, F. (2008). Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients’ cells lacking its components. J Clin Endocrinol Metab 93:1433–1441.
   PubMed Web of Science ®Google Scholar
• Beekmann, S. E., Gilbert, D. N., Polgreen, P. M.; the IDSA Emerging Infections Network. (2008). Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey. Diagn Microbiol Infect Dis ( In press).
   PubMed Web of Science ®Google Scholar
• Bolt, M. W., Card, J. W., Racz, W. J., Brien, J. F., Massey, T. E. (2001). Disruption of mitochondrial function and cellular ATP levels by amiodarone and N-desethylamiodarone in initiation of amiodarone-induced pulmonary cytotoxicity. J Pharmacol Exp Ther 298:1280–1289.
   PubMed Web of Science ®Google Scholar
• Breucking, E., Mortier, W., Lampert, R., Brandt, L. (1993). Anesthesia and intensive therapy for a patient with mitochondrial myopathy. Anaesthesist 42:719–723.
   PubMed Web of Science ®Google Scholar
• Briere, J. J., Schlemmer, D., Chretien, D., Rustin, P. (2004). Quinone analogues regulate mitochondrial substrate competitive oxidation. Biochem Biophys Res Commun 316:1138–1142.
   PubMed Web of Science ®Google Scholar
• Brunmair, B., Lest, A., Staniek, K., Gras, F., Scharf, N., Roden, M., et al. (2004). Fenofibrate impairs rat mitochondrial function by inhibition of respiratory complex I. J Pharmacol Exp Ther 311:109–114.
   PubMed Web of Science ®Google Scholar
• Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., et al. (2004). Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 53:1052–1059.
   PubMed Web of Science ®Google Scholar
• Cai, Y., Nelson, B. D., Li, R., Luciakova, K., dePierre, J. W. (1996). Thyromimetic action of the peroxisome proliferators clofibrate, perfluorooctanoic acid, and acetylsalicylic acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis. Arch Biochem Biophys 325:107–112.
   PubMed Web of Science ®Google Scholar
• Carvalho, C., Correia, S., Santos, M. S., Seiça, R., Oliveira, C. R., Moreira, P. I. (2008). Metformin promotes isolated rat liver mitochondria impairment. Mol Cell Biochem 308:75–83.
   PubMed Web of Science ®Google Scholar
• Casademont, J., Garrabou, G., Miró, O., López, S., Pons, A., Bernardo, M., et al. (2007). Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients. J Clin Psychopharmacol 27:284–288.
   PubMed Web of Science ®Google Scholar
• Cheam, E. W., Critchley, L. A. (1998). Anesthesia for a child with complex I respiratory chain enzyme deficiency. J Clin Anesth 10:524–527.
   PubMed Web of Science ®Google Scholar
• Chen, P. S., Wang, C. C., Bortner, C. D., Peng, G. S., Wu, X., Pang, H., et al. (2007). Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 149:203–212.
   PubMed Web of Science ®Google Scholar
• Chen, Q., Moghaddas, S., Hoppel, C. L., Lesnefsky, E. J. (2006). Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J Pharmacol Exp Ther 319:1405–1412.
   PubMed Web of Science ®Google Scholar
• Cherry, C. L., Lala, L., Wesselingh, S. L. (2005). Mitochondrial toxicity of nucleoside analogues: mechanism, monitoring, and management. Sex Health 2:1–11.
   PubMedGoogle Scholar
• Chiyonobu, T., Noda, R., Yoshida, M., Fujiki, A., Ishii, R., Nukina, S., et al. (2008). Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) associated with phenytoin therapy. Brain Dev 30:430–433.
   PubMed Web of Science ®Google Scholar
• Choi, C., Sunwoo, I. N., Kim, H. S., Kim, D. I. (2000). Transient improvement of pyruvate metabolism after coenzyme Q therapy in Kearns-Sayre syndrome: MRS study. Yonsei Med J 41:676–679.
   PubMed Web of Science ®Google Scholar
• Cocco, T., Cutecchia, G., Montedoro, G., Lorusso, M. (2002). The antihypertensive drug, carvedilol, inhibits the activity of mitochondrial NADH-ubiquinone oxidoreductase. J Bioenerg Biomembr 34:251–258.
   PubMed Web of Science ®Google Scholar
• Cooper, J. M., Schapira, A. H. (2003). Friedreich’s ataxia: disease mechanisms, antioxidant, and coenzyme Q10 therapy. Biofactors 18:163–171.
   PubMed Web of Science ®Google Scholar
• Cushing, H. (1932). The basophil adenomas of the pituitary body and their clinical manifestations. John Hopkins Med J 50:137.
   Google Scholar
• Devi, B. G., Chan, A. W. (1997). Impairment of mitochondrial respiration and electron transport chain enzymes during cocaine-induced hepatic injury. Life Sci 60:849–855.
   PubMed Web of Science ®Google Scholar
• Devin, A., Nogueira, V., Avéret, N., Leverve, X., Rigoulet, M. (2006). Profound effects of the general anesthetic etomidate on oxidative phosphorylation without effects on their yield. J Bioenerg Biomembr 38:137–142.
   PubMed Web of Science ®Google Scholar
• dos Santos, N. A., Martins, N. M., Curti, C., Pires Bianchi, Mde L., dos Santos, A. C. (2007). Dimethylthiourea protects against mitochondrial oxidative damage induced by cisplatin in liver of rats. Chem Biol Interact 170:177–186.
   PubMed Web of Science ®Google Scholar
• El-Mir, M. Y., Detaille, D., R?-Villanueva, G., Delgado-Esteban, M., Guigas, B., Attia, S., et al. (2008). Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons. J Mol Neurosci 34:77–87.
   PubMed Web of Science ®Google Scholar
• Farag, E., Argalious, M., Narouze, S., DeBoer, G. E., Tome, J. (2002). The anesthetic management of ventricular septal defect (VSD) repair in a child with mitochondrial cytopathy. Can J Anaesth 49:958–962.
   PubMed Web of Science ®Google Scholar
• Finsterer, J., Gelpi, E. (2006). Mitochondrial disorder aggravated by propranolol. South Med J 99:768–771.
   PubMed Web of Science ®Google Scholar
• Finsterer, J., Zuntner, G. (2005). Rhabdomyolysis from simvastatin triggered by infection and muscle exertion. South Med J 98:827–829.
   PubMed Web of Science ®Google Scholar
• Finsterer, J., Jarius, C., Eichberger, H. (2001). Phenotype variability in 130 adult patients with respiratory chain disorders. J Inherit Metab Dis 24:560–576.
   PubMed Web of Science ®Google Scholar
• Finsterer, J., Haberler, C., Schmiedel, J. (2005). Deterioration of Kearns-Sayre syndrome following articaine administration for local anesthesia. Clin Neuropharmacol 28:148–149.
   PubMed Web of Science ®Google Scholar
• Finsterer, J., Harbo, H. F., Baets, J., van Broeckhoven, C., Di Donato, S., Fontaine, B., et al. (2008). EFNS guidelines on the molecular diagnosis of mitochondrial disorders. Eur J Neurol 2009 ( In press).
   Web of Science ®Google Scholar
• Finsterer, J., Stratil, U., Bittner, R., Sporn, P. (1998). Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy. Can J Anaesth 45:781–784.
   PubMed Web of Science ®Google Scholar
• Fodale, V., La Monaca E., (2008). Propofol infusion syndrome: an overview of a perplexing disease. Drug Saf 31:293–303.
   PubMed Web of Science ®Google Scholar
• Fritz, T., Lenz, G., Schorer, R. (1998). Comments on anesthesia procedures in mitochondrial encephalomyopathy. Anasth Intensivther Notfallmed 23:265–270.
   Google Scholar
• Fromenty, B., Pessayre, D. (1995). Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther. 67:101–154.
   PubMed Web of Science ®Google Scholar
• Gioltzoglou, T., Cordivari, C., Lee, P. J., Hanna, M. G., Lees, A. J. (2005). Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature. J Neurol Neurosurg Psychiatry 76:1594–1596.
   PubMed Web of Science ®Google Scholar
• Guigas, B., Detaille, D., Chauvin, C., Batandier, C., De Oliveira, F., Fontaine, E., et al. (2004). Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study. Biochem J 382:877–884.
   PubMed Web of Science ®Google Scholar
• Haas, R., Stumpf, D. A., Parks, J. K., Eguren, L., (1981). Inhibitory effects of sodium valproate on oxidative phosphorylation. Neurology 31:1473–1476.
   PubMed Web of Science ®Google Scholar
• Hanley, P. J., Ray, J., Brandt, U., Daut, J. (2002). Halothane, isoflurane, and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol 544(Pt 3):687–693.
   PubMed Web of Science ®Google Scholar
• Hara, K., Sata, T., Shigematsu, A. (2004). Anesthetic management for cardioverter-defibrillator implantation in a patient with Kearns-Sayre syndrome. J Clin Anesth 16:539–541.
   PubMed Web of Science ®Google Scholar
• Heinke, W., Schaffranietz, L. (2004). Anaesthesia for combined pancreatic and renal transplantation in a patient with mitochondrial encepahalomyopathy—case report. Anaesthesiol Reanim 29:87–90.
   PubMedGoogle Scholar
• Ishiguro, M., Hashimoto, K., Hayakata, Y., Fukunaga, S., Seo, N. (2006). Prolonged respiratory depression after fentanyl administration in a patient with mitochondrial encephalomyopathy. Masui 55:73–75.
   PubMedGoogle Scholar
• Itaya, K., Takahata, O., Mamiya, K., Saito, T., Tamakawa, S., Akama, Y., et al. (1995). Anesthetic management of two patients with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Masui 44:710–712.
   PubMedGoogle Scholar
• Johnson, T. E., Zhang, X, Shi, S., Umbenhauer, D. R. (2005). Statins and PPARalpha agonists induce myotoxicity in differentiated rat skeletal muscle cultures but do not exhibit synergy with co-treatment. Toxicol Appl Pharmacol 208:210–221.
   PubMed Web of Science ®Google Scholar
• Kam, P. C., Cardone, D. (2007). Propofol infusion syndrome. Anaesthesia 62:690–701.
   PubMed Web of Science ®Google Scholar
• Kayihan, N., Nennesmo, I., Ericzon, B. G., Németh, A. (2000). Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid-induced liver damage. Pediatr Transpl 4:211–214.
   PubMedGoogle Scholar
• Kim, J. Y., Lee, H. W. (2007). Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy. Epilepsia 48:1366–1370.
   PubMed Web of Science ®Google Scholar
• Kirpichnikov, D., McFarlane, S. I., Sowers, J. R. (2002). Metformin: an update. Ann Intern Med 137:25–33.
   PubMed Web of Science ®Google Scholar
• Kitoh, T., Mizuno, K., Otagiri, T., Ichinose, A., Sasao, J., Goto, H. (1995). Anesthetic management for a patient with Kearns-Sayre syndrome. Anesth Analg 80:1240–1242.
   PubMed Web of Science ®Google Scholar
• Klepper, J., Leiendecker, B., Riemann, E., Baumeister, F. A. (2004). The ketogenic diet in German-speaking countries: update 2003. Klin Padiatr 216:277–285.
   PubMed Web of Science ®Google Scholar
• Klockgether-Radke, A., Henze, T., Braun, U., Kettler, D. (1993). General anesthesia in two patients with mitochondrial myopathy. Anaesthesist 42:111–114.
   PubMed Web of Science ®Google Scholar
• Koga, Y., Akita, Y., Junko, N., Yatsuga, S., Povalko, N., Fukiyama, R., et al. (2006). Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology 66:1766–1769.
   PubMed Web of Science ®Google Scholar
• Koga, Y., Akita, Y., Nishioka, J., Yatsuga, S., Povalko, N., Tanabe, Y., et al. (2005). L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 64:710–712.
   PubMed Web of Science ®Google Scholar
• Kohro, S., Hogan, Q. H., Nakae, Y., Yamakage, M., Bosnjak, Z. J. (2001). Anesthetic effects on mitochondrial ATP-sensitive K channel. Anesthesiology 95:1435–1440.
   PubMed Web of Science ®Google Scholar
• Krähenbühl, S., Brandner, S., Kleinle, S., Liechti, S., Straumann, D. (2000). Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure. Liver 20:346–348.
   PubMedGoogle Scholar
• Kushikata, T., Yatsu, Y., Kubota, T., Matsuki, A. (2004). Total intravenous anesthesia with propofol, ketamine, and fentanyl (PFK) for a patient with mitochondrial myopathy. Masui 53:178–180.
   PubMedGoogle Scholar
• Laforêt, P., Nicolino, M., Eymard, B. (2007). New approaches for the treatment of metabolic myopathies. Rev Neurol (Paris) 163:930–935.
   PubMed Web of Science ®Google Scholar
• Lam, C. W., Lau, C. H., Williams, J. C., Chan, Y. W., Wong, L. J. (1997). Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) triggered by valproate therapy. Eur J Pediatr 156:562–564
   PubMed Web of Science ®Google Scholar
• Langsjoen, P. H., Langsjoen, A., Willis, R., Folkers, K. (1997). Treatment of hypertrophic cardiomyopathy with coenzyme Q10. Mol Aspects Med 18(Suppl):S145–S151.
   PubMedGoogle Scholar
• Lechner, J., Malloth, N., Seppi, T., Beer, B., Jennings, P., Pfaller, W. (2008). IFN-alpha induces barrier destabilization and apoptosis in renal proximal tubular epithelium. Am J Physiol Cell Physiol 294:C153–C160.
   Web of Science ®Google Scholar
• Ledl, M., Hohenecker, J., Francesconi, C., Roots, I., Bauer, M. F., Roden, M. (2005). Acute myopathy in a type 2 diabetic patient on combination therapy with metformin, fenofibrate, and rosiglitazone. Diabetologia 48:1996–1998.
   PubMed Web of Science ®Google Scholar
• Létuvé, S., Druilhe, A., Grandsaigne, M., Aubier, M., Pretolani, M. (2002). Critical role of mitochondria, but not caspases, during glucocorticosteroid-induced human eosinophil apoptosis. Am J Respir Cell Mol Biol 26:565–571.
   PubMed Web of Science ®Google Scholar
• Lin, C. M., Thajeb, P. (2007). Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA. Metab Brain Dis 22:105–109.
   PubMed Web of Science ®Google Scholar
• Looareesuwan, S., Chulay, J. D., Canfield, C. J., Hutchinson, D. B. (1999). Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. Am J Trop Med Hyg 60:533–541.
   PubMed Web of Science ®Google Scholar
• Luís, P. B., Ruiter, J. P., Aires, C. C., Soveral, G., de Almeida, I. T., Duran, M., et al. (2007). Valproic acid metabolites inhibit dihydrolipoyl dehydrogenase activity leading to impaired 2-oxoglutarate-driven oxidative phosphorylation. Biochim Biophys Acta 1767:1126–1133.
   PubMed Web of Science ®Google Scholar
• Maeda, Y., Mitsumizo, S., Yoshida, M., Nakashima, M., Harano, K., Totoki, T. (2001). Perioperative administration of bicarbonated solution to a patient with mitochondrial encephalomyopathy. Masui 50:299–303.
   PubMedGoogle Scholar
• Mancuso, M., Galli, R., Pizzanelli, C., Filosto, M., Siciliano, G., Murri, L. (2006). Antimyoclonic effect of levetiracetam in MERRF syndrome. J Neurol Sci 243:97–99.
   PubMed Web of Science ®Google Scholar
• Marriage, B., Clandinin, M. T., Glerum, D. M. (2003). Nutritional cofactor treatment in mitochondrial disorders. J Am Diet Assoc 103:1029–1038.
   PubMed Web of Science ®Google Scholar
• Matsuno, S., Hashimoto, H., Matsuki, A. (1994). Neuroleptanesthesia for a patient with mitochondrial encephalomyopathy. Masui 43:1038–1040.
   PubMedGoogle Scholar
• McFarland, R., Hudson, G., Taylor, R. W., Green, S. H., Hodges, S., McKiernan, P. J., et al. (2008). Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1). Arch Dis Child 93:151–153.
   PubMed Web of Science ®Google Scholar
• Mitra, M. S., Donthamsetty, S., White, B., Mehendale, H. M. (2008). High-fat-diet–fed obese rats are highly sensitive to doxorubicin-induced cardiotoxicity. Toxicol Appl Pharmacol 231:413–422.
   PubMed Web of Science ®Google Scholar
• Modica-Napolitano, J. S., Lagace, C. J., Brennan, W. A., Aprille, J. R. (2003). Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro. Arch Pharm Res 26:951–959.
   PubMed Web of Science ®Google Scholar
• Monros, E., Pineda, M. (2002). Friedreich’s ataxia: idebenone treatment in early stage patients. Neuropediatrics 33:190–193.
   PubMed Web of Science ®Google Scholar
• Mottin, S., Laporte, P., Cespuglio, R. (2003). Inhibition of NADH oxidation by chloramphenicol in the freely moving rat measured by picosecond time-resolved emission spectroscopy. J Neurochem 84:633–642.
   PubMed Web of Science ®Google Scholar
• Mythili, Y., Sudharsan, P. T., Varalakshmi, P. (2005). dl-alpha-lipoic acid ameliorates cyclophosphamide induced cardiac mitochondrial injury. Toxicology 215:108–114.
   PubMed Web of Science ®Google Scholar
• Naguib, M., el-Dawlatly, A. A., Ashour, M., al-Bunyan, M. (1996). Sensitivity to mivacurium in a patient with mitochondrial myopathy. Anesthesiology 84:1506–1509.
   PubMed Web of Science ®Google Scholar
• Napolitano, A., Salvetti, S., Vista, M., Lombardi, V., Siciliano, G., Giraldi, C. (2000). Long-term treatment with idebenone and riboflavin in a patient with MELAS. Neurol Sci 21(Suppl 5):S981–S982.
   PubMed Web of Science ®Google Scholar
• Nissim, I., Horyn, O., Daikhin, Y., Nissim, I., Luhovyy, B., Phillips, P. C., et al. (2006). Ifosfamide-induced nephrotoxicity: mechanism and prevention. Cancer Res 66:7824–7831.
   PubMed Web of Science ®Google Scholar
• Nouette-Gaulain, K., Sirvent, P., Canal-Raffin, M., Morau, D., Malgat, M., Molimard, M., et al. (2007). Effects of intermittent femoral nerve injections of bupivacaine, levobupivacaine, and ropivacaine on mitochondrial energy metabolism and intracellular calcium homeostasis in rat psoas muscle. Anesthesiology 106:1026–1034.
   PubMed Web of Science ®Google Scholar
• Novalija, E., Kevin, L. G., Eells, J. T., Henry, M. M., Stowe, D. F. (2003). Anesthetic preconditioning improves adenosine triphosphate synthesis and reduces reactive oxygen species formation in mitochondria after ischemia by a redox dependent mechanism. Anesthesiology 98:1155–1163.
   PubMed Web of Science ®Google Scholar
• Oliveira, P. J., Gonçalves, L., Monteiro, P., Providencia, L. A., Moreno, A. J. (2005). Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria? Curr Vasc Pharmacol 3:147–158.
   PubMedGoogle Scholar
• Ortiz-Gómez, J. R., Souto-Ferro, J. M. (2006). Anesthesia for a patient with mitochondrial respiratory chain complex III deficiency. Rev Esp Anestesiol Reanim 53:575–579.
   PubMedGoogle Scholar
• Oshima, Y., Kuroda, Y., Kunishige, M., Matsumoto, T., Mitsui, T. (2004). Oxidative stress-associated mitochondrial dysfunction in corticosteroid-treated muscle cells. Muscle Nerve 30:49–54.
   PubMed Web of Science ®Google Scholar
• Päivä, H., Thelen, K. M., Van Coster, R., Smet, J., De Paepe, B., Mattila, K. M., et al. (2005). High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clin Pharmacol Ther 78:60–68.
   PubMed Web of Science ®Google Scholar
• Pearce, R. J., Duchen, M. R. (1995). Electrophysiological and metabolic effects of a convulsant barbiturate on dissociated mouse primary sensory neurons. J Physiol 483:407–420.
   PubMed Web of Science ®Google Scholar
• Perronne, C. (2006). Antiviral hepatitis and antiretroviral drug interactions. J Hepatol 44(Suppl):S119–S125.
   PubMedGoogle Scholar
• Pessayre, D., Mansouri, A., Haouzi, D., Fromenty, B. (1999). Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 15:367–373.
   PubMed Web of Science ®Google Scholar
• Rasmussen, M., Sanengen, T., Skullerud, K., Kvittingen, E. A., Skjeldal, O. H. (2000). Evidence that Alpers-Huttenlocher syndrome could be a mitochondrial disease. J Child Neurol 15:473–477.
   PubMed Web of Science ®Google Scholar
• Reeve, J. L., Szegezdi, E., Logue, S. E., Chonghaile, T. N., O’Brien, T., Ritter, T., et al. (2007). Distinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-xL. J Cell Mol Med 11:509–520.
   PubMed Web of Science ®Google Scholar
• Sabaté, S., Ferrándiz, M., Paniagua, P., Villamor, J. M., Vilanova, F., Villar-Landeira, J. M. (1996). Anesthesia in Kearns-Sayre syndrome (mitochondrial myopathy). Rev Esp Anestesiol Reanim 43:255–257.
   PubMedGoogle Scholar
• Saitoh, A., Haas, R. H., Naviaux, R. K., Salva, N. G., Wong, J. K., Spector, S. A. (2008). Impact of nucleoside reverse transcriptase inhibitors on mitochondrial DNA and RNA in human skeletal muscle cells. Antimicrob Agents Chemother 52:2825–2830.
   PubMed Web of Science ®Google Scholar
• Scatena, R., Bottoni, P., Martorana, G. E., Ferrari, F., De Sole, P., Rossi, C., et al. (2004). Mitochondrial respiratory chain dysfunction, a non-receptor-mediated effect of synthetic PPAR-ligands: biochemical and pharmacological implications. Biochem Biophys Res Commun 319:967–973.
   PubMed Web of Science ®Google Scholar
• Schols, L., Meyer, C. H., Schmid, G., Wilhelms, I., Przuntek, H. (2004). Therapeutic strategies in Friedreich’s ataxia. J Neural Transm (Suppl):135–145.
   Google Scholar
• Schols, L., Zange, J., Abele, M., Schillings, M., Skipka, G., Kuntz-Hehner, S., et al. (2005). L-carnitine and creatine in Friedreich’s ataxia. A randomized, placebo-controlled crossover trial. J Neural Transm 112:789–796.
   PubMed Web of Science ®Google Scholar
• Scruggs, E. R., Dirks Naylor, A. J. (2008). Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy. Pharmacology 82:83–88.
   PubMed Web of Science ®Google Scholar
• Sgobbo, P., Pacelli, C., Grattagliano, I., Villani, G, Cocco, T. (2007). Carvedilol inhibits mitochondrial complex I and induces resistance to H2O2-mediated oxidative insult in H9C2 myocardial cells. Biochim Biophys Acta 1767:222–232.
   PubMed Web of Science ®Google Scholar
• Shapira, Y., Cederbaum, S. D., Cancilla, P. A., Nielsen, D., Lippe, B. M. (1975). Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia. Neurology 25:614–621.
   PubMed Web of Science ®Google Scholar
• Sharma, A. D., Erb, T., Schulman, S. R., Sreeram, G., Slaughter, T. F. (2001). Anaesthetic considerations for a child with combined Prader-Willi syndrome and mitochondrial myopathy. Paediatr Anaesth 11:488–490.
   PubMedGoogle Scholar
• Shenkman, Z., Krichevski, I., Elpeleg, O. N., Joseph, A., Kadari, A. (1997). Anaesthetic management of a patient with Leigh’s syndrome. Can J Anaesth 44:1091–1095.
   PubMed Web of Science ®Google Scholar
• Shibukawa, K., Kawamata, M., Seki, S., Narimatsu, E., Namiki, A. (2002). The use of propofol combined with nitrous oxide and fentanyl in anesthetic management of a patient with mitochondrial encephalomyopathy. Masui 51:888–891.
   PubMedGoogle Scholar
• Short, T. G., Young, Y. (2003). Toxicity of intravenous anaesthetics. Best Pract Res Clin Anaesthesiol 17:77–89.
   PubMedGoogle Scholar
• Silva, M. F., Ruiter, J. P., Illst, L., Jakobs, C., Duran, M., de Almeida, I. T., et al. (1997). Valproate inhibits the mitochondrial pyruvate-driven oxidative phosphorylation in vitro. J Inherit Metab Dis 20:397–400.
   PubMed Web of Science ®Google Scholar
• Tatsumi, Y., Nakashima, M., Kitao, T., Kan, K., Tomita, T., Hashimoto, Y., et al. (2006). Anesthetic management of a patient with mitochondrial encephalomyopathy under total intravenous anesthesia. Masui 55:1228–1230.
   PubMedGoogle Scholar
• Thiel, A., Ritzka, M., Saur, G. (2001). Anesthesia in mitochondrial encephalomyopathies. Anaesthesiol Intensivmed Notfallmed Schmerzther 36:437–439.
   PubMed Web of Science ®Google Scholar
• Thompson, V. A, Wahr, J. A. (1997). Anesthetic considerations in patients presenting with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Anesth Analg 85:1404–1406.
   PubMed Web of Science ®Google Scholar
• Toribe, Y., Tominaga, K., Ogawa, K., Suzuki, Y. (2007). Usefulness of L-arginine infusion for status epilepticus in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. No To Hattatsu 39:38–43.
   PubMedGoogle Scholar
• Toth, G., Morava, E., Bene, J., Selhorst, J. J., Overmars, H., Vreken, P., et al. (2001). Carnitine-responsive carnitine insufficiency in a case of mtDNA 8993TC mutation associated Leigh syndrome. J Inherit Metab Dis 24:421–422.
   PubMed Web of Science ®Google Scholar
• Tovo, P. A., Chiapello, N., Gabiano, C., Zeviani, M., Spada, M. (2005). Zidovudine administration during pregnancy and mitochondrial disease in the offspring. Antivir Ther 10:697–699.
   PubMed Web of Science ®Google Scholar
• Trost, L. C., Lemasters, J. J. (1996). The mitochondrial permeability transition: a new pathophysiological mechanism for Reye’s syndrome and toxic liver injury. J Pharmacol Exp Ther 278:1000–1005.
   PubMed Web of Science ®Google Scholar
• Tzoulis, C., Engelsen, B. A., Telstad, W., Aasly, J., Zeviani, M., Winterthun, S., et al. (2006). The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129:1685–1692.
   PubMed Web of Science ®Google Scholar
• Van Maldergem, L., Trijbels, F., DiMauro, S., et al. (2002). Coenzyme Q-responsive Leigh’s encephalopathy in two sisters. Ann Neurol 52:750–754.
   PubMed Web of Science ®Google Scholar
• Vilela, H., Garcìa-Fernández, J., Parodi, E., Reinoso-Barbero, F., Durán, P., Gilsanz, F. (2005). Anesthetic management of a patient with MERRF syndrome. Paediatr Anaesth 15:77–79.
   PubMed Web of Science ®Google Scholar
• Vladutiu, G. D. (2008). Genetic predisposition to statin myopathy. Curr Opin Rheumatol 20:648–655.
   PubMed Web of Science ®Google Scholar
• Walker, U. A. (2000). Mitochondrial medicine for internists. Med Klin (Munich) 95:689–696.
   PubMed Web of Science ®Google Scholar
• Wisely, N. A., Cook, P. R. (2001). General anaesthesia in a man with mitochondrial myopathy undergoing eye surgery. Eur J Anaesthesiol 18:333–335.
   PubMed Web of Science ®Google Scholar
• Yamamoto, M., Akiyama, C., Aikawa, H. (1990). D-penicillamine-induced copper deficiency in suckling mice: neurological abnormalities and brain mitochondrial enzyme activities. Brain Res Dev Brain Res 55:51–55.
   PubMedGoogle Scholar
• Yunis, A. A. (1989). Chloramphenicol toxicity: 25 years of research. Am J Med 87:44N–48N.
   PubMed Web of Science ®Google Scholar
• Zaugg, M., Lucchinetti, E., Spahn, D. R., Pasch, T., Garcia, C., Schaub, M. C. (2002). Differential effects of anesthetics on mitochondrial K(ATP) channel activity and cardiomyocyte protection. Anesthesiology 97:15–23.
   PubMed Web of Science ®Google Scholar